Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?
To evaluate the necessity of duplicate testing for prothrombin times (PTs) and activated partial thromboplastin times (APTTs), the range of differences between duplicate sample results was analyzed on a widely used automated photo-optical coagulation instrument. Specimens with coagulation test times ranging from normal to threefold above the reference range were included. Of 1,610 PTs and 1,023 APTTs, approximately 95% of duplicates differed by 0.2 s or less and 2.0 s or less, respectively. Approximately 99% of PTs and APTTs differed by 0.4 s or less and 4.0 s or less, respectively; there were three PT and 16 APTT specimens whose duplicates differed by a greater time interval and also by more than 5% of the mean. Thus, PT and APTT testing on automated instrumentation is very precise, but occasional inaccurate single measurements could lead to errors in diagnosis or therapy.
D001780:Blood Coagulation Tests; D006801:Humans; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time; D011786:Quality Control; D012016:Reference Values